Treatment outcomes for multidrug-resistant tuberculosis in Eastern Taiwan

Chih Bin Lin, Hung Chieh Sun, Chen Yuan Chiang, Che Wei Wu, Hsu Wen Chou, Tao Qian Tang, Jen Jyh Lee

研究成果: 雜誌貢獻文章同行評審

3 引文 斯高帕斯(Scopus)

摘要

Objectives: The objective of this study is to evaluate the treatment outcomes of patients with multidrug-resistant tuberculosis (MDR-TB) under special programmatic management in Eastern Taiwan over the past 10 years. Materials and Methods: All newly diagnosed MDR-TB patients and MDR-TB patients enrolled previously with persistent positive cultures were included in this study, from May 2007 to April 2017, in Eastern Taiwan. A panel of pulmonologists designed the initial MDR-TB regimens. Subsequently, regimens were adjusted according to drug susceptibility test results for second-line drugs. Mobile teams were organized for treatment support, and several measures were adapted to safeguard effective treatment support. Results: A total of 178 patients with bacteriological confirmed pulmonary MDR-TB were identified, of whom 167 had treatment outcomes when the study was conducted. Of these 167 patients, 120 (71.9%) were cured, 11 (6.5%) completed therapy (78.4% had successful treatment), 25 (15.0%) died, 9 (5.4%) had treatment failure, none were transferred out, and 2 (1.2%) were lost to follow-up. Surgery was performed on 8 (4.8%). Conclusions: This is an analysis of the treatment outcomes after adopting the Directly Observed Treatment, Short-course Plus program to treat MDR-TB patients in Eastern Taiwan. We had a low proportion of loss-to-follow-up, resulting in a high treatment success rate. This program serves as an effective model in providing quality care to patients with MDR-TB.
原文英語
頁(從 - 到)35-39
頁數5
期刊Tzu Chi Medical Journal
31
發行號1
DOIs
出版狀態已發佈 - 一月 1 2019

ASJC Scopus subject areas

  • 醫藥 (全部)

指紋

深入研究「Treatment outcomes for multidrug-resistant tuberculosis in Eastern Taiwan」主題。共同形成了獨特的指紋。

引用此